Abstract

Simple SummaryAquaculture is the world’s fastest-growing food production sector, with tilapia (Oreochromis spp.) among the most important cultured species. First reported in red seabream, Pagrus major, in 1990, an increasing number of megalocytiviruses are responsible for losses that threaten the production and economic sustainability of important cultured fish species, including tilapia. In the current study, we describe an epizootic in tilapia fingerlings from Southern California, USA and report the discovery of a novel megalocytivirus associated with the mortalities. In spring 2019, diseased four-month-old tilapia (Oreochromis spp.) from an aquaculture farm in Southern California, USA were received for diagnostic evaluation with signs of lethargy, anorexia, abnormal swimming, and low-level mortalities. At necropsy, non-specific external lesions were noted including fin erosion, cutaneous melanosis, gill pallor, and coelomic distension. Internal changes included ascites, hepatomegaly, renomegaly, splenomegaly, and multifocal yellow-white nodules in the spleen and kidney. Cultures of spleen and kidney produced bacterial colonies identified as Francisella orientalis. Homogenized samples of gill, brain, liver, spleen, and kidney inoculated onto Mozambique tilapia brain cells (OmB) developed cytopathic effects, characterized by rounding of cells and detaching from the monolayer 6–10 days post-inoculation at 25 °C. Transmission electron microscopy revealed 115.4 ± 5.8 nm icosahedral virions with dense central cores in the cytoplasm of OmB cells. A consensus PCR, targeting the DNA polymerase gene of large double-stranded DNA viruses, performed on cell culture supernatant yielded a sequence consistent with an iridovirus. Phylogenetic analyses based on the concatenated full length major capsid protein and DNA polymerase gene sequences supported the tilapia virus as a novel species within the genus Megalocytivirus, most closely related to scale drop disease virus and European chub iridovirus. An intracoelomic injection challenge in Nile tilapia (O. niloticus) fingerlings resulted in 39% mortality after 16 days. Histopathology revealed necrosis of head kidney and splenic hematopoietic tissues.

Highlights

  • Tilapia (Oreochromis spp.) are one of the most important cultured fish groups worldwide, with annual global production estimated at over 7.5 million tons and a value of 11 billion USD in 2020 [1]

  • Diagnostic investigation of diseased tilapia farmed in California demonstrated co-infection with F. orientalis and a novel megalocytivirus

  • Sequence analysis of a 609 bp PCR product amplified from the DNA polymerase gene of the virus exhibited the highest similarity (92%) to that of the SDDV, a unique megalocytivirus described from Lates calcarifer experiencing mortalities and characteristic skin lesions in Southeast Asia [29,30]

Read more

Summary

Introduction

Tilapia (Oreochromis spp.) are one of the most important cultured fish groups worldwide, with annual global production estimated at over 7.5 million tons and a value of 11 billion USD in 2020 [1]. Tilapia aquaculture represents a major source of affordable animal protein, in developing countries in tropical and subtropical regions of Africa, Asia, and Latin America [2]. Infectious diseases pose a major threat to the sustainability of tilapia farming. While the majority of diseases in tilapia aquaculture are of bacterial origin (e.g., francisellosis, streptococcosis, columnaris disease), viral pathogens such as tilapia lake virus (TiLV) [3], tilapia parvovirus [4], and infectious spleen and kidney necrosis virus (ISKNV) [5,6] have emerged as significant threats to the industry. Iridoviruses (family Iridoviridae) are large (120–350 nm), structurally complex, icosahedral particles with linear, double-stranded DNA genomes encoding over 100 open reading frames. The family Iridoviridae is comprised of two subfamilies: Alphairidovirinae and Betairidovirinae

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call